In our study, the results of the survival analysis of key genes showed that AKT1, MAPK1, CASP3, MMP9, TP53, and PTGS2 had statistical differences in the OS or RFS of NSCLC patients (p < 0.05) (Figure 8). The gene discussed is MMP9; the disease is non-small cell lung carcinoma.